POSC131 Events Avoided and Cost Savings Associated with the Use of Intravenous Ferric Carboxymaltose for the Treatment of Iron Deficiency in Patients Stabilized after an Acute Heart Failure Episode with Reduced Ejection Fraction in the UK
Abstract
Authors
P McEwan P Ponikowski J Davis G Rosano AJS Coats F Dorigotti D O'Sullivan A Ramirez de Arellano Serna EA Jankowska